Jinzhu Chen PhD - 25 May 2021 Form 4 Insider Report for Oncternal Therapeutics, Inc.

Role
Director
Signature
/s/Chase C. Leavitt, Attorney-in-fact
Issuer symbol
N/A
Transactions as of
25 May 2021
Net transactions value
$0
Form type
4
Filing time
27 May 2021, 18:06:17 UTC
Next filing
17 Jun 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ONCT Stock Options Award $0 +50,000 $0.000000 50,000 25 May 2021 Common Stock 50,000 $5.14 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 One thirty-sixth of the shares subject to the option vest and become exercisable in substantially equal installments on each monthly anniversary of the date of grant, such that the shares subject to the option shall be fully vested on the three-year anniversary of the date of grant, subject to the Reporting Person's continued service on the Board through each such vesting date.